. Whole cell patch-clamp techniques were used to examine neurokinin receptor modulation of Ca 2ϩ channels in small to medium size dorsal root ganglia neurons (Ͻ40 pF) that express mainly N-and L-type Ca 2ϩ currents. Low concentrations of substance P enhanced Ca 2ϩ currents (5-40%, Ͻ0.2 M), while higher concentrations applied cumulatively reversed these enhancements (5-28% reductions, Ͼ0.5 M). This apparent inhibition by high concentrations of substance P was blocked by the administration of the NK 3 antagonist SB 235,375 (0.2 M). ]-neurokinin B had no effect. Activation of protein kinase C with low concentrations of phorbol-12,13-dibutyrate enhanced Ca 2ϩ currents, but high concentrations inhibited N-and L-type Ca 2ϩ currents. In summary, these data suggest that in adult rat dorsal root ganglia neurons, NK 2 receptors enhance both L-and N-type Ca 2ϩ channels and NK 3 receptors inhibit N-type Ca 2ϩ channels and that these effects are mediated by protein kinase C phosphorylation of Ca 2ϩ channels.
channels in DRG neurons of the adult rat. J Neurophysiol 90: 21-31, 2003 . First published March 26, 2003 10.1152 /jn.00108.2003 . Whole cell patch-clamp techniques were used to examine neurokinin receptor modulation of Ca 2ϩ channels in small to medium size dorsal root ganglia neurons (Ͻ40 pF) that express mainly N-and L-type Ca 2ϩ currents. Low concentrations of substance P enhanced Ca 2ϩ currents (5-40%, Ͻ0.2 M), while higher concentrations applied cumulatively reversed these enhancements (5-28% reductions, Ͼ0.5 M). This apparent inhibition by high concentrations of substance P was blocked by the administration of the NK 3 antagonist SB 235,375 (0.2 M). The NK 1 agonist, [Sar 9 ,Met 11 ]-substance P (0.05 to 1.0 M) did not alter Ca 2ϩ currents; whereas the NK 2 agonist, [␤Ala 8 ]-neurokinin A (4 -10), enhanced Ca 2ϩ currents (5-36% increase, 0.05-0.5 M). The enhancement was reversed by the NK 2 antagonist MEN 10,376 (0.2 M) but unaffected by the NK 3 antagonist SB 235,375 (0.2 M). The NK 3 agonist [MePhe 7 ]-neurokinin B (0.5-1.0 M) inhibited Ca 2ϩ currents (6 -24% decrease). This inhibition was not prevented by the NK 2 antagonist MEN 10,376 (0.2 M) but was blocked by the NK 3 antagonist SB 235,375 (0.2 M). Both the enhancement and inhibition of Ca 2ϩ currents by neurokinin agonists were reversed by the protein kinase C inhibitor bisindolylmaleimide I HCl (0.2-0.5 M). Following inhibition of Ca 2ϩ channels by [MePhe 7 ]-neurokinin the facilitatory effect of BayK 8644 (5 M) was increased and the inhibitory effect of the N-type Ca 2ϩ channel blocker w -conotoxin GVIA (1 M) was diminished, suggesting that the NK 3 agonist inhibits N-type Ca 2ϩ channels. Similarly, block of all but N-type Ca 2ϩ channels, revealed that [␤Ala 8 ]-neurokinin A (4 -10) enhanced the currents while [MePhe 7 ]-neurokinin B inhibited the currents. Inhibition of all but L-type Ca 2ϩ channels, revealed that [␤Ala 8 ]-neurokinin A (4 -10) enhanced the currents while [MePhe 7 ]-neurokinin B had no effect. Activation of protein kinase C with low concentrations of phorbol-12,13-dibutyrate enhanced Ca 2ϩ currents, but high concentrations inhibited N-and L-type Ca 2ϩ currents. In summary, these data suggest that in adult rat dorsal root ganglia neurons, NK 2 receptors enhance both L-and N-type Ca 2ϩ channels and NK 3 receptors inhibit N-type Ca 2ϩ channels and that these effects are mediated by protein kinase C phosphorylation of Ca 2ϩ channels.
I N T R O D U C T I O N
Neurokinins such as substance P and neurokinin A, which are synthesized and released from sensory neurons (Johnson et al. 1998; Marco et al. 1998; Otsuka and Yoshioka 1993; Zogorodnyuc and Maggi 1997) , contribute to numerous physiological processes, including inflammatory responses (Jia and Seybold 1996) , nociception (Liu and Sandkuhler 1997) , central and peripheral cardiovascular regulation (Thompson et al. 1998) , urinary bladder function (Kiss et al. 2001; Tramontana et al. 1998) , and other autonomic reflexes (Moodley et al. 1999; Serio et al. 1998) . The role of neurokinins in central and peripheral nociceptive mechanisms has been examined in considerable detail (Cheunsuang and Morris 2000; Hunt 2000; Laird et al. 2000; McLeod et al. 1999) . Thermal hyperalgesia associated with neuropathic and inflammatory pain is reduced after ablation of substance P-containing spinal neurons with substance P-saporin (Nichols et al. 1999) . Knockout mice lacking functional NK 1 receptors show deficits in perception of visceral pain (intracolonic capsaicin) and do not develop hyperalgesia and edema in response to noxious stimuli (Laird et al. 2000) . On the other hand, transgenic mice overexpressing substance P show hyperalgesia that is reversed by substance P antagonists (McLeod et al. 1999) . It is also important to note that mice with a deletion of the preproneurokinin A gene, which codes for both substance P and neurokinin A, lack several responses associated with noxious stimuli (e.g., plasma extravasation) and fail to detect the normal range of intensities of nociceptive stimuli, although they respond normally to acute pain tests (Basbaum 1999) . These mice also exhibit impaired responses to chemical irritation of the urinary bladder (Kiss et al. 2001) .
Different neurokinins preferentially activate three types of receptors: substance P for NK 1 , neurokinin A for NK 2 , and neurokinin B for NK 3 (Maggi 1995) . There is evidence for expression of all three types of receptors in dorsal root ganglia neurons, although they may be differentially expressed in the cell bodies and terminals of these neurons (Brechenmacher et al. 1998; Hu et al. 1997; Malcangio and Bowery 1999; Schmid et al. 1998 ). More selective neurokinin receptors agonists and antagonists have been developed recently and allow for more precise characterization of the receptors involved in various physiological responses (Lippe et al. 1997; Maggi and Schwartz 1997; Matuszek et al. 1998; Torrens et al. 1997) .
In addition to mediating transmission between primary afferent neurons and peripheral target organs or second order neurons in the CNS, neurokinins may also act on autoreceptors on afferent nerve terminals to regulate terminal excitability (Wen and Morrison 1996) or transmitter release (D'Agostino et al. 2000; Malcangio and Bowery 1999) . Neurokinin autoreceptors are thought to be linked through G proteins to protein kinase C (and/or other protein kinases), which in turn can phosphorylate and modulate Ca 2ϩ channels (Hall et al. 1995; Harding et al. 1999; Murase et al. 1989; Schmid et al. 1998 ). L-type Ca 2ϩ channels have been implicated in neuropeptide release from sensory neurons (Harding et al. 1999; Holz et al. 1988; Perney et al. 1986; Rane et al. 1987; Yoshizawa et al. 1989) , whereas N-type Ca 2ϩ channels may be involved in the release of glutamic acid (Gruner and Silva 1995; Winkler 1997) . SP or protein kinase C are known to enhance Ca 2ϩ currents in many cell types (Mayer et al. 1990; Murase et al. 1989; Sims et al. 1988; Womack et al. 1986 ), including dorsal root ganglia neurons (Hall et al. 1995) . However, activation of protein kinase C has also been reported to inhibit Ca 2ϩ currents (McMahon et al. 2000) . Thus the effect and identity of neurokinin auto-receptors subtypes and the signaling mechanisms activated by neurokinin receptors to modulate Ca 2ϩ channels in dorsal root ganglia neurons requires further study.
In the present experiments, we examined the effect of three types of neurokinin receptor agonists and antagonists on Ca 2ϩ currents in dissociated dorsal root ganglia neurons from adult rats. Our data suggest that activation of NK 2 receptors enhances both L-type and N-type Ca 2ϩ currents, while activation of NK 3 receptors inhibits N-type Ca 2ϩ currents. These responses are antagonized by the selective protein kinase Cinhibitor, bisindolylmaleimide, suggesting that they are mediated by activation of protein kinase C.
M E T H O D S
Experiments were conducted on 179 dorsal root ganglia neurons from adult male rats maintained in primary cultures for 2-10 days.
Cell preparation
Single cells were isolated by standard enzymatic techniques as previously described (Sculptoreanu et al. 1995) . Freshly dissected ganglia were minced and washed in cold, oxygenated DMEM (Sigma). This was followed by a brief, 10-min dissociation at 37°C in DMEM containing 0.5 mg/ml trypsin (Sigma). After a 10-min centrifugation, the media was replaced with DMEM containing 1 mg/ml collagenase B (Boehringer-Mannheim) and 0.5 mg/ml trypsin inhibitor type 1S (Sigma). Dissociation of neurons was monitored and every 10 min the cells gently triturated with siliconized Pasteur pipettes. After the ganglia were dissociated into individual neurons (25-40 min), the cell suspension was centrifuged for 10 min at 1,200 rpm. The pellet was layered on 20 ml of 50% adult bovine serum (Sigma) and DMEM and centrifuged again at 800 rpm. This step removed most of the debris and broken cells. The pellet was resuspended in DMEM containing 10% heat inactivated horse serum and 5% fetal bovine serum (Sigma) and plated on collagen coated 35 mm petri dishes (Collaborative Research, Biocoat). Neurons were plated at low density (2,000 -3,000 per dish). Primary cultures were kept in a 95% O 2 -5% CO 2 incubator at 37°C.
Recording
The whole cell patch-clamp technique was used to record Ca 2ϩ currents in dorsal root ganglia neurons. Patch pipettes were pulled from capillary glass tubes (Accufil 90, Clay-Adams) on a horizontal puller (Model P8 PC, Sutter Instruments) and fire polished. Immediately before recording, the serum containing media was replaced with Ca 2ϩ containing solutions. Whole cell currents were recorded using an Axopatch 1D (Axon Instruments) patch-clamp amplifier. Pulse generation, current recording, and data analysis used pClamp software (Axon Instruments). Curve fitting was done using Sigma Plot software (Jandel Scientific). Currents were sampled at 50 -500 ms, filtered at 2 kHz, and capacitative current and Յ80% of the series resistance was compensated. A p/4 protocol was used to subtract uncompensated capacitative currents and leak currents.
For whole cell recordings, modified physiological solutions were used to suppress Na ϩ , Kϩ, and Cl Ϫ channel currents. The pipette (intracellular) solution consisted of (in M) 130 N-methyl-D-glucamine, 20 EGTA (free acid), 5 BAPTA, 10 HEPES, 6 Mg(OH) 2 , 4 Ca(OH) 2 , 3 (Mg)ATP, 0.3 (Li) GTP, and 0.3 (Na) cAMP, pH buffered to 7.3 with methanesulfonic acid. The external solution contained (in M) 20 Ca(OH) 2 , 60 tetraethyl ammonium (OH), 40 tris [hydroxyethyl] aminomethane (Trizma base), 5 4-aminopyridine, and 10 HEPES, pH buffered to 7.4 with methane-sulfonic acid. In these recording solutions, Ca 2ϩ currents run-up during the initial 1-3 min of recording (Sculptoreanu et al., 1995) . Drugs were added after recording stable currents for an additional 1-3 min. (Research Biochemicals) , and the PKC inhibitor bisindolylmaleimide I HCl (Calbiochem) were dissolved in DMSO (100 M) and used at Ͻ0.01% of their stock concentration. At these dilutions, DMSO alone had no effect on calcium channel currents. Stock solutions in 10 -100 M were stored at Ϫ20°C and diluted in the external recording solution just before experiments. Extracellularly applied drugs were pipetted from stock solutions at 10 to 100 times the final concentration and rapidly mixed in the recording chamber as described previously (Sculptoreanu et al. 1995) . Steadystate effects of each drug concentration were measured for Ն2-3 min before changing the drug concentration or adding a new drug.
Pharmacology
R E S U L T S Cultured dorsal root ganglia neurons ranged in size from 18 -50 mm diam and had capacitances of 20 -90 pF. The experiments were performed on neurons with capacitances below 40 pF. The resting membrane potentials averaged Ϫ45 to Ϫ68 mV, and the amplitude of Ca 2ϩ currents evoked by depolarizing current pulses to 0 mV from a holding potential of -80 mV ranged from 0.2 to 5.0 nA and roughly correlated with soma size. As noted in previous studies (Scroggs and Fox 1991; Sculptoreanu et al. 1995; Yoshimura et al. 2001) currents by 51 Ϯ 5% (n ϭ 21, Table 1 ), whereas nitrendipine (5 M), an L-type channel blocker, reduced the currents by 34 Ϯ 6% (n ϭ 17); 23 Ϯ 9% of the current remained after combined -conotoxin GVIA-nitrendipine treatment (n ϭ 14). These remaining currents were reduced to 12 Ϯ 8% of control currents by a combination of Q-and P-type channel blockers (-conotoxin MVIIC, 0.5 M, n ϭ 5 and -agatoxin IVA, 0.1 M, n ϭ 5 or -agatoxin TK, 0.1 M, n ϭ 4). Bay K 8644 (5 M), a dihydropyridine agonist that is known to enhance L-type Ca 2ϩ currents (Sculptoreanu et al. 1995) , consistently enhanced the currents in either untreated neurons or after the application of other agents such as -conotoxin GVIA or neurokinins (Table 1) .
Dual effect of substance P in dorsal root ganglia neurons
The effects of substance P and other agonists and inhibitors were studied with cumulative addition of drugs ( Fig. 1) . A test pulse near the peak of the current voltage relationship of Ca 2ϩ currents (0 mV), 50 or 500 ms in duration, was repeated at 5-to 20-s intervals. Drugs were added to the bath and rapidly mixed. At most, three concentrations of substance P were tested on each cell. Changes in currents occurred within 2 min or less after each concentration was tested, and steady-state effects were measured for 1-2 min prior to raising drug concentrations ( Fig. 1) . Preliminary experiments revealed that substance P in a low concentration (Ͻ0.2 M) facilitated Ca 2ϩ currents (9 -35% increase, n ϭ 10, Fig. 1A ). In subsequent experiments (n ϭ 35 neurons), several concentrations of substance P were added to the bath at 5-to 10-min intervals to construct cumulative concentration response curves (Figs. 1 and 2). Various concentrations of substance P were tested (in M: 0.05, n ϭ 25; 0.1, n ϭ 14; 0.2, n ϭ 23; 0.5, n ϭ 12; 1.0, n ϭ 4). Substance P concentrations between 0.05 and 0.2 M enhanced Ca 2ϩ currents (5-40% increase), whereas at concentrations of substance P above 0.5 M, the enhancements were progressively reduced ( Fig. 2A, E) . This reduction in Ca 2ϩ current enhancements at higher substance P concentrations was abolished in the presence of SB 235,375 (0.2 M), an NK 3 antagonist (Hay et al. 2002) , added either before or after substance P (Fig. 1A or 2A, F). Treatment with SB 235,375 did not alter Ca 2ϩ currents in the absence of substance P ( Fig. 2A ) but did increase the currents (10 -35%) in the presence of substance P at all concentrations tested (0.05-1.0 M, n ϭ 15 cells tested; Fig. 2A, F) . For example, in the presence of 0.2 M of substance P, addition of SB 235,375 (0.2 M) significantly increased Ca 2ϩ currents (26 Ϯ 5%, n ϭ 6, P Ͻ 0.01, Figs. 1A and 2A). In the presence of substance P and SB 235,375, application of -conotoxin GVIA markedly reduced the currents; whereas Bay K 8644 facilitated the currents (Table 1) .
In a separate series of experiments, the facilitatory effect of 0.2 M substance P on Ca 
The averages of relative steady-state effects of -conotoxin GVIA and Bay K 8644 as percent increase (ϩ) or decrease (Ϫ) of peak currents after the neurokinin agonists, or substance P and the NK 3 antagonist, SB 235,375. Results are compared with the effect of -conotoxin GVIA (1 M stance P and not due to a direct inhibition of Ca 2ϩ currents by bisindolylmaleimide.
Lack of effect of an NK 1 agonist in dorsal root ganglia neurons
The NK 1 agonist [Sar 9 , Met 11 ]-substance P (sar,metSP) did not alter Ca 2ϩ currents in dorsal root ganglia neurons (n ϭ 13) at concentrations ranging between 0.05 and 1 M. At most, three increasing concentrations were added in sequence for each cell tested and currents were measured for 5-10 min for each concentration. Current densities for control and after sar,metSP were unchanged as follows: control (n ϭ 9): 26.8 Ϯ 2.7 pA/pF; 0.05 M (n ϭ 7): 27.4 Ϯ 0.3 pA/pF; 0.1 M (n ϭ 9): 28.1 Ϯ 0.5 pA/pF; 0.2 M (n ϭ 4): 26.9 Ϯ 1 pA/pF; 0.5 M (n ϭ 8): 26.7 Ϯ 0.3 pA/pF; 1.0 M (n ϭ 8): 26.3 Ϯ 0.5 pA/pF. In another series of experiments, the PKC inhibitor bisindolylmaleimide (0.5 M, n ϭ 3; 1.0 M, n ϭ 4) had no effect after 0.2 M [Sar 9 , Met 11 ]-substance P (0.5 M). In these experiments current densities were 28.3 Ϯ 3.2 pA/pF in the control recordings and 25.9 Ϯ 2.7 pA/pF after the NK 1 agonist [Sar 9 , Met 11 ]-substance P, and were not changed by bisindolylmaleimide (0.5 M, 25.9 Ϯ 2.7 pA/pF; 1.0 M, 26.3 Ϯ 0.4 pA/pF). This suggests that protein kinase C inhibitor was devoid of nonspecific effects on Ca 2ϩ currents and that dorsal root ganglia neurons have little endogenous protein kinase C activity under the recording conditions used here (Fomina and Levitan 1997 Fig. 3 , n ϭ 12 cells tested). The enhancement of Ca 2ϩ currents (5-60% increase) occurred within 2 min, and steady-state effects were measured for 1-2 min prior to raising drug concentrations. Administration of an NK 3 inhibitor, SB 235,375 (0.2 M, n ϭ 6; 0.5 M, n ϭ 4), before or after 0.2 M of the NK 2 agonist did not prevent the enhancement of currents by [␤Ala 8 ]-neurokinin A (4 -10) (Fig. 3, A2 and B) . At most, three increasing concentrations of the drug were added in sequence for each cell tested. In a separate series of experiments, the NK 2 receptor antagonist MEN 10,376 (0.2 M) reversed the enhancement of Ca 2ϩ currents induced by 0.2 M (n ϭ 4) or 0.5 M (n ϭ 4) [␤Ala 8 ]-neurokinin A (4 -10) (Fig. 3, A3 and B). In three of these experiments, after reversal of enhancement by 0.2 M [␤Ala 8 ]-neurokinin A (4 -10), addition of 0.5 M agonist in the presence of the NK 2 antagonist no longer had an effect. These data suggest that [␤Ala 8 ]-neurokinin A (4 -10) is a specific agonist for NK 2 receptors and had little or no effect on NK 3 receptors. Figure 3C shows an additional experiment in which bisindolylmaleimide reversed the stimulation of Ca 2ϩ currents by 0.2 M [␤Ala 8 ]-neurokinin A (4 -10), which produced a 35% enhancement. After stable currents were recorded (Fig. 1) , current-voltage relationships were generated by a series of depolarizing pulses from Ϫ60 to ϩ70 mV (Fig. 3C) . (Fig. 4B , P Ͻ 0.001). These data suggest that this agonist may have weak NK 2 effects. In a separate series of experiments, the protein kinase C inhibitor bisindolylmaleimide (0.5 M, n ϭ 6) reversed the inhibition of Ca 2ϩ currents by 0.2 M [MePhe 7 ]-neurokinin B (Fig. 4C) . In another series of experiments, application of bisindolylmaleimide (0.5 M) before 0.2 M of [MePhe 7 ]-neurokinin B (n ϭ 3) prevented the inhibitory effects (12% inhibition) of the NK 3 agonist. After stable currents were recorded (Fig. 1) , current-voltage relationships were generated by a series of depolarizing pulses from Ϫ60 to ϩ70 mV (Fig. 4C) ]-neurokinin B inhibited the currents (26.5 Ϯ 0.9 pA/pF); 0.5 M of bisindolylmaleimide reversed this inhibition to control magnitudes (29.8 Ϯ 0.7 pA/pF). These data suggest the inhibitory action of the NK 3 agonist is due to protein kinase C phosphorylation of Ca 2ϩ channels.
Phorbol 12,13-dibutyrate modulates L-and N-type Ca 2ϩ currents in dorsal root ganglia neurons
The reversal of NK 2 -and NK 3 -mediated effects by the protein kinase C inhibitor suggests that protein kinase C may participate in both facilitatory and inhibitory modulation of Ca 2ϩ currents. Figures 5 and 6 summarize experiments in which we tested the effect of a protein kinase C activator, phorbol 12,13-dibutyrate (0.05-90 M). Phorbol 12,13-dibutyrate both enhanced and inhibited calcium currents (Fig. 5) . Enhancement occurred at low concentrations (0.05-1.0 M, n ϭ 4, Figs. 5A and 6), and inhibition occurred at higher concentrations (25-90 M, n ϭ 6, Figs. 5B and 6A). At most, five increasing concentrations of phorbol 12,13-dibutyrate were added in sequence for each cell tested (n ϭ 22), and currents were measured for at least 1 min after steady-state effect at each concentration tested. The enhancement by 0.2 M phorbol 12,13-dibutyrate was reversed by bisindolylmaleimide ( Fig. 6B ; 0.2 M, n ϭ 4). In these cells -conotoxin GVIA (1 M, n ϭ 6) or a combination of -conotoxin GVIA and Bay K 8644 (n ϭ 3) produced effects similar to those in the previous series of experiments; notably, a Ͼ50% inhibition of currents in response to the N-type Ca 2ϩ channel blocker and a Ͼ40% enhancement by the L-type Ca 2ϩ channel agonist after -conotoxin GVIA block. This suggests that these small dorsal root ganglia neurons expressed relatively large levels of N-and L-type Ca 2ϩ currents. To evaluate more directly the types of Ca 2ϩ channels affected by phorbol 12,13-dibutyrate, the effects of various antagonists were tested. As shown in Fig. 6C , when Ca 2ϩ currents were blocked by a combination of P-type Ca 2ϩ channel blocker -agatoxin IVA (0.05 M), L-type Ca 2ϩ channel blocker nitrendipine (5 M), and T-type Ca 2ϩ channel blocker flurenzipine (200 M), phorbol 12,13-dibutyrate (0.05 M, n ϭ 5; 0.10 M, n ϭ 4; 0.20 M, n ϭ 6) still enhanced the currents, and bisindolylmaleimide (0.2 M, n ϭ 6; 0.5 M, n ϭ 4) reversed the enhancement. The N-type Ca 2ϩ channel blocker -conotoxin GVIA blocked between 49 Ϯ 6% (1 M, n ϭ 4) and 89 Ϯ 3% (10 M, n ϭ 6) of these agatoxindihydropyridine-flurenzipine-insensitive currents. Ca 2ϩ currents blocked by a combination of -agatoxin IVA (0.05 M) and -conotoxin GVIA (1 M) and enhanced by 5 M Bay K 8644 were also increased by 0.2 M phorbol 12,13-dibutyrate (Fig. 6D, n ϭ 6 had an effect (data not shown). This suggests that the NK 2 agonist, and low concentrations of the phorbol 12,13-dibutyrate, may activate phosphorylation of the same sites on Ca 2ϩ channels.
Subtypes of Ca 2ϩ channels are modulated selectively by neurokinins receptors
The interactions between the neurokinins and -conotoxin GVIA and Bay K 8644 were also used to evaluate the types of Ca 2ϩ channels affected by the neurokinins. We reasoned that if a neurokinin selectively enhanced or suppressed N-or L-type Ca 2ϩ channels, the magnitude of the effect of -conotoxin GVIA or Bay K 8644 would be changed in the presence of that neurokinin. As shown in Table 1 ]-neurokinin A (4 -10) but was enhanced (34% increase) in the presence of [MePhe 7 ]-neurokinin B. This change is also consistent with the view that the NK 3 agonist suppresses N-type Ca 2ϩ currents, thereby increasing the relative contribution of L-type Ca 2ϩ currents to the total current and thus increasing the magnitude of the BayK 8644 -induced facilitation. This idea was further tested in another series of experiments (Fig. 7) .
As shown in Fig -Conotoxin GVIA (1 M, n ϭ 6) or a combination of -conotoxin GVIA and Bay K 8644 (n ϭ 3) were added after maximum enhancement of calcium currents by 0.2 M phorbol 12,13-dibutyrate. C: Ca 2ϩ currents blocked by a combination of P-type Ca 2ϩ channel blocker -agatoxin IVA (A, 0.05 M), L-type blocker nitrendipine (Nt, 5 M), and T-type blocker flurenzipine (200 M) were enhanced by phorbol 12,13-dibutyrate (0.05, n ϭ 5; 0.10, n ϭ 4; 0.20, n ϭ 6; in M). Bisindolylmaleimide (0.2 M, n ϭ 6; 0.5 M, n ϭ 4) reversed the enhancement of Ca 2ϩ currents by 0.2 M phorbol 12,13-dibutyrate. The N-type Ca 2ϩ channel blocker -conotoxin GVIA blocked over 50% of these agatoxin-DHP-insensitive currents at 1 M (n ϭ 4) and over 90% of the currents at 10 M (n ϭ 6). D : Ca 2ϩ currents blocked by a combination of agatoxin (Aga, 0.05 M), -conotoxin GVIA (1 M), and enhanced by 5 M Bay K 8644 were also increased by 0.05 M or 0.2 M PDB (n ϭ 6). This enhancement was reversed by 0.2 M bisindolylmaleimide. Data in A-D are averages of current densities, SE, and statistical difference (2-tailed t-test, unequal variance, *P Ͻ 0.05, **P Ͻ 0.01, number of neurons indicated in parentheses). Fig. 7D , n ϭ 6). However, this effect was not statistically significant (P ϭ 0.66). The L-type Ca 2ϩ channel blocker nitrendipine (5 M) blocked 90% of this current, indicating that it was mostly L-type Ca 2ϩ current (Fig. 7D) . Insets in Fig.  7 show control currents after block of all but N-type Ca 2ϩ currents with a combination of blockers (Fig. 7, A and B Note that the N-type currents in Fig. 7 , A and B, typically activate and inactivate more rapidly than the L-type currents in 7, C and D. The slow inactivation of L-type Ca currents is apparent even when longer test pulses, 500 ms in duration, are used (Fig. 7D ).
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D I S C U S S I O N
The present results indicate that small size dorsal root ganglia neurons (Ͻ40 pF or Ͻ20 m diam) express two types of neurokinin receptors (NK 2 and NK 3 ), which exert opposite modulatory effects (facilitatory and inhibitory) on high-thresh- channel blocker -conotoxin GVIA (1 M, GVIA) blocked the NKA-inhibited current (n ϭ 5). Inse: control currents (con) in 1 experiment, after block of all but N-type Ca 2ϩ currents with a combination of blockers as in A, and after NKB and GVIA (in that order). C: effect of NKA (0.5 M) on L-type Ca 2ϩ currents after block of N-, Q-, and P-type Ca 2ϩ currents with -conotoxin GVIA (1 M, GVIA), -conotoxin MVIIC (0.5 M, MVIIC), and -agatoxin TK (0.1 M, Aga TK) and NK3 antagonist, SB 235, 375 (0.5 M) . The L-type Ca 2ϩ channel blocker nitrendipine (5 M, Nitr) blocked the NKA-stimulated current (n ϭ 8). Inset: control currents (con) in 1 experiment, after block of all but L-type Ca 2ϩ currents with a combination of blockers as in C, and after NKA and nitrendipine (NITR, in that order) . D: effect of NKB (0.5 M) on L-type Ca 2ϩ currents after block of N-, Q-, and P-type Ca 2ϩ currents with -conotoxin GVIA (1 M, GVIA), -conotoxin MVIIC (0.5 M, MVIIC), and -agatoxin TK (0.1 M, Aga TK) and NK2 antagonist, MEN 10,376 (0.5 M). The L-type Ca 2ϩ channel blocker nitrendipine (5 M, Nitr) blocked the current after a small but statistically not significant inhibition by NKB (n ϭ 8). Inset: control currents (con) in 1 experiment, after block of all but L-type Ca 2ϩ currents with a combination of blockers as in C, and after NKB and nitrendipine (NITR, in that order). Data in A-D are averages of current densities, SE, and statistical difference (2-tailed t-test, unequal variance, *P Ͻ 0.05, **P Ͻ 0.01, number of neurons indicated as inset).
old voltage-gated Ca 2ϩ channels via intracellular signaling mechanisms, which involve protein kinase C. Our data suggest that NK 1 receptors in dorsal root ganglia neurons do not modulate Ca 2ϩ currents. Our data are consistent with the idea that activation of NK 2 receptors mediates the enhancement of both L-an N-type Ca 2ϩ channels, while activation of NK 3 receptors mainly leads to inhibition of N-type Ca 2ϩ channels in small dorsal root ganglia neurons (Fig. 7) . The existence of NK 2 and NK 3 receptors in the soma of dorsal root ganglia neurons raises the possibility that if similar receptors are present in the nerve terminals in the periphery and in the spinal cord, endogenously released neurokinins may control afferent excitability and transmitter release by activating these receptors.
Subtypes of neurokinin receptors that modulate Ca 2ϩ channel activities in dorsal root ganglia neurons
The conclusion that NK 2 and NK 3 exert opposite modulatory effects in dorsal root ganglia neurons is based on the complex effects of substance P as well as on the effects of selective neurokinin agonists and antagonists. For example, substance P enhanced Ca 2ϩ currents at concentrations below 0.2 M, but at higher concentrations the enhancement of the current gradually diminished (Fig. 2) . This might be attributable to receptor desensitization during repeated administration of substance P. However, this explanation seems unlikely because an NK 3 antagonist prevented the decline in the facilitatory response and enhanced the facilitatory responses to high concentrations of substance P. Thus facilitation of Ca 2ϩ currents by low concentrations of substance P and apparent reversal of facilitation by higher concentration must be mediated by different receptors. The finding that low concentrations of substance P produce facilitation and high concentrations reverse this facilitation is consistent with the greater affinity of substance P for NK 2 versus NK 3 receptors (Torrens et al. 1997) . The failure to demonstrate receptor-mediated inhibition with sequential application of increasing concentrations of substance P raises the possibility that prior activation of NK 2 receptors with low concentrations of substance P might downregulate the NK 3 -mediated inhibition or that the NK 3 receptors partially desensitize during prolonged exposure to substance P.
The conclusions regarding the actions of substance P are supported by the effects of more selective neurokinin agonists. The NK 2 -specific agonist [␤Ala 8 ]-neurokinin A (4 -10) enhanced the Ca 2ϩ currents to a magnitude similar to that seen with substance P after inhibition of NK 3 receptors with SB 235,375. The NK 2 receptor antagonist MEN 10,376 reversed the enhancement of Ca 2ϩ currents by [␤Ala 8 ]-neurokinin A (4 -10). On the other hand, the selective NK 3 agonist [MePhe 7 ]-neurokinin B inhibited Ca 2ϩ currents, and this effect was blocked the NK 3 receptor antagonist. Thus various evidence indicates that two types of neurokinin receptors with opposing effects on Ca 2ϩ channels can be expressed in the same dorsal root ganglia neuron. The experiments in Fig. 7 demonstrate that, while NK 2 receptor activation facilitates both N-and L-type Ca 2ϩ currents, activation of NK 3 receptors mainly inhibits N-type Ca 2ϩ currents. Although other studies have identified inhibitory effects of neurokinins on ion channels in various types of neurons, this is the first report of a neuronal inhibitory action that can be attributed to NK 3 receptors. Substance P was shown to inhibit Ca 2ϩ -dependent K ϩ -channels and other K ϩ channels (Gilbert et al. 1998; Otsuka and Yoshioka 1993; Phenna et al. 1996) ; however, the subtype of neurokinin receptor involved was not established. In nucleus basalis cholinergic neurons, substance P inhibits N-but not L-type Ca 2ϩ channel currents (MargetaMitrovic et al. 1997 ), but again the type of receptor mediating this effect is not known. On the other hand, NK 3 receptors have been implicated in neuronal excitatory effects mediated by activation of nonspecific cation channels (Hardwick et al. 1997; Hu et al. 1997) . Substance P released from the soma or terminals of dorsal root ganglia neurons may thus facilitate its own release by activation of nonselective cation channels that are partially permeable to calcium ions (Hu et al. 1997; Schmid et al. 1998) . Indeed, it has been reported that activation of NK 3 receptors can enhance the K ϩ -evoked release of substance P from capsaicin-sensitive synaptosomes obtained from the rat spinal cord (Schmid et al. 1998) . These data suggest that NK 3 receptors might have a facilitatory autoreceptor function at central afferent terminals, whereas our data would suggest the opposite effect. Clearly, the significance of this difference between the two series of experiments will have to be explored in further studies.
Protein kinase C is the mediator of NK 2 and NK 3 receptor action on Ca 2ϩ currents
The enhancement of Ca 2ϩ currents by NK 2 receptors (Fig.  3) as well as the inhibition of Ca 2ϩ currents by NK 3 receptors (Fig. 4) was reversed by the protein kinase C inhibitor bisindolylmaleimide at concentrations that had no direct effects (Fig. 2C ) on basal Ca 2ϩ currents either before or after the administration of the inactive NK 1 agonist, [Sar 9 , Met 11 ]-substance P (Fig. 2) . Further indirect support for a role of protein kinase C in the neurokinin receptor signaling pathway was produced by experiments with the phorbol ester, phorbol 12,13-dibutyrate, which both enhanced (at low concentrations) and inhibited (at high concentrations) Ca 2ϩ channel currents in dorsal root ganglia neurons. These changes were also reversed by bisindolylmaleimide (Fig. 6) . The facilitatory effect of phorbol 12,13-dibutyrate was not prevented by blocking L-or N-type Ca 2ϩ channels individually with appropriate antagonists, indicating that both types of Ca 2ϩ channels are facilitated by activation of protein kinase C. Similarly, the effects of -conotoxin GVIA or Bay K 8644 were unaffected by enhancement of Ca 2ϩ channels by either substance P or the NK 2 agonist. This suggests that both N-and L-type Ca 2ϩ channels may be enhanced by activation of NK 2 . This conclusion is consistent with previous findings by Hall et al. (1995) , which suggested that both N-and L-type Ca 2ϩ currents are increased by a constitutively active protein kinase C injected intracellularly in dorsal root ganglia neurons. Protein kinase C has also been reported to increase L-and N-type Ca 2ϩ currents in central dopaminergic neurons (Uramura et al. 2001) . Other types of Ca 2ϩ channels presumably contribute very little to the facilitatory effects of phorbol 12,13-dibutyrate because blockers of P-and T-type Ca 2ϩ channels did not alter the facilitation in our experiments. Since phorbol 12,13 dibutyrate enhanced both N-and L-type Ca 2ϩ channels, it is reasonable to conclude that the action of NK 2 receptors to enhance L-and N-type Ca 2ϩ channels in dorsal root ganglia neurons by activating protein kinase C occurs in a similar fashion. (Catalioto et al. 1998; Takeda et al. 1992) and NK 3 (Melcangio and Bowery 1999) receptors are coupled by a pertussis-insensitive G protein to phospholipase C and protein kinase C activation. The large inhibitory effects of high concentrations of phorbol 12,13 dibutyrate also suggest that, unlike [MePhe 7 ]-neurokinin B or substance P-mediated attenuation of facilitation, phorbol 12,13 dibutyrate may be reducing both L-and N-type Ca 2ϩ channel activities in dorsal root ganglia neurons or may have direct, nonspecific effects on Ca 2ϩ channels above certain concentrations.
Protein kinase C is activated by signal transduction mechanisms that stimulate the break down of phospholipids by phospholipase C and/or D to generate diacyl glycerol and IP 3 . The protein kinase C (PKC) family consists of Ն12 different polypeptides (Hug and Sarre 1993) . Protein kinase C subtypes can be divided in three major groups, according to their primary structure and functional similarities: 1) Ca 2ϩ -dependent or conventional (c), PKC c , which needs both Ca 2ϩ and diacylglycerol for activation; 2) Ca 2ϩ -independent or novel (n), PKC n ; and 3) atypical (a), PKC a , which requires neither Ca 2ϩ nor diacylglycerol for activation (Way et al. 2000) . Different PKC isoforms may exhibit different substrate specificity and subcellular distribution (Mochly-Rosen and Gordon 1998). One way to confer selectivity to such a diverse group of isoenzymes is through specific anchoring proteins (Csukai and Mochly-Rosen 1999; Mochly-Rosen and Gordon 1998) . A question that would be purely speculative at this stage is whether the facilitatory or inhibitory effects reported here would be mediated by different protein kinase C subtypes with substrate specificity, selective coupling of NK 2 and NK 3 receptors with different subtypes of protein kinase C, or some other cellular localization mechanism. This deserves further investigation. Indeed, the well-known upregulation of L-type Ca 2ϩ channels by chronic ethanol exposure is mediated selectively by PKC␦ and the upregulation of N-type Ca 2ϩ channels is inhibited by a selective peptide inhibitor of PKC⑀, although both of these effects are at the level of gene regulation rather than phosphorylation of Ca 2ϩ channel subtypes (McMahon et al. 2000) . Use of selective PKC activators and inhibitors suggested that PKC⑀ is the isoform responsible for inhibition of voltage-dependent Ca 2ϩ channels in adrenal chromaffin cells, although the identity of Ca 2ϩ channel subtype was not determined (Sena et al. 2001) . In neurons from the major pelvic ganglion of rats, PKC activated by a selective M 1 agonist preferentially upregulated only the L-type Ca 2ϩ currents, although both N-and L-type Ca 2ϩ channels are expressed in these neurons (Sculptoreanu et al. 2001) .
Possible implication of neurokinin modulation of Ca 2ϩ channels in the release of peptide neurotransmitters
Since both L-and N-type Ca 2ϩ channels seem to be involved in release of neuropeptides, including neurokinins (Kageyama et al. 1997) , and the peptide release sites (large granular synaptic vesicles, Otsuka and Yoshioka 1993) may be distant to the conventional docked-small vesicle release sites, neurokinin autoreceptors (Harding et al. 1999; Malcangio and Bowery 1999) would be expected to modulate their own release with PKC activation as an intermediary in the process (Barber and Vasko 1996; Hingtgen and Vasko 1994) and might modulate the release of other neurotransmitters (Malcangio and Bowery 1999) . Thus the mechanism of Ca 2ϩ channel modulation we describe here may have important consequences in modulation of neurotransmitter release.
